Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

Abstract #101299

Russel Falck, MA, Jichuan Wang, PhD, and Robert G. Carlson, PhD. Community Health, Wright State University, 3640 Colonel Glenn Hwy., Dayton, OH 45435, 937-775-2066, russel.falck@wright.edu

Research suggests that MDMA can cause serotonin depletion as well as serotonergic neurodegradation that may result in depression among users of the drug. This longitudinal study uses the latest version of the BDI to assess current depressive symptomatology among a community sample of young adult MDMA users (n=402). The BDI was administered at baseline and again one year later. Multivariate analysis was used to identify sociodemographic and drug use variables associated with changes in BDI scores as well as transitions between diagnostic categories.

Learning Objectives: At the conclusion of the session, participants will be able to

(
• discuss the use of the BDI to assess depression; (
• identify factors associated with changes in BDI scores; (
• discuss the implications findings may have for prevention and treatment programs targeting MDMA users.

Keywords: Drug Use, Depression

Presenting author's disclosure statement:

I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.